S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations

被引:34
作者
Becker, A
Smulders, YM
Teerlink, T
Struys, EA
de Meer, K
Kostense, PJ
Jakobs, C
Dekker, JM
Nijpels, G
Heine, RJ
Bouter, LM
Stehouwer, CDA
机构
[1] VU Univ Med Ctr, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands
[2] VU Univ Med Ctr, Inst Res Extramural Med, NL-1081 HV Amsterdam, Netherlands
[3] VU Univ Med Ctr, Inst Cardiovasc Res, NL-1081 HV Amsterdam, Netherlands
[4] VU Univ Med Ctr, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands
[5] VU Univ Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
关键词
cardiovascular disease; cobalamin; folate; homocysteine; intervention trials; S-adenosylhomocysteine; S-adenosylmethionine; vitamin B-6; PLASMA HOMOCYSTEINE LEVELS; STAGE RENAL-DISEASE; VASCULAR-DISEASE; RISK FACTOR; CARDIOVASCULAR-DISEASE; HORDALAND-HOMOCYSTEINE; HEART-DISEASE; HYPERHOMOCYSTEINEMIA; DETERMINANTS; POPULATION;
D O I
10.1046/j.1365-2362.2003.01104.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is unclear whether homocysteine itself is causal in the pathogenesis of cardiovascular disease. Alternatively or additionally, the association between homocysteine and cardiovascular disease may be because of its metabolic precursor, S-adenosylhomocysteine, or of the ratio of S-adenosylmethionine to S-adenosylhomocysteine. Therefore, it is relevant to know how these moieties are interrelated, and whether, as is the case for homocysteine, they are influenced by blood levels of folate, cobalamin or vitamin B-6. Design We cross-sectionally studied A population-based cohort of 97 Caucasian subjects aged 60-85 years. Concentrations of homocysteine, S-adenosylhomocysteine, S-adenosylmethionine, folate, cobalamin and vitamin B6 were measured in fasting blood samples. Results In multiple regression analysis, homocysteine was associated with vitamin B12 (per 50 pmol L-1 increase of cobalamin, change in homocysteine, -0.70 mmol L-1; 95% CI, -1.30 to -0.10 mmol L-1) and folate (per 100 mnol L-1 increase in erythrocyte folate, change in homocysteine,-0.68 mmol L-1; 95% CI-1.28 to -0.08 mmol. L-1). S-adenosylhomocysteine, S-adenosylmethionine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine were not associated with serum folate, cobalamin or vitamin B6, nor with erythrocyte folate. Furthermore, plasma homocysteine showed a negative correlation with the ratio of Sadenosylmethionine to S-adenosylhomocysteine in plasma (r = -0.27; P < 0.01) but not in erythrocytes. Conclusions In contrast to homocysteine, the plasma concentrations of S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine were not associated with the folate, cobalamin and vitamin B6 concentrations in the present study. If these precursors in part explain why homocysteine is associated with cardiovascular disease, homocysteine-lowering treatment with B vitamins may be less effective than currently expected, at least in an elderly population.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 45 条
[41]   Homocysteine metabolism in renal failure [J].
van Guldener, C ;
Stam, F ;
Stehouwer, CDA .
KIDNEY INTERNATIONAL, 2001, 59 :S234-S237
[42]   Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis:: a randomised, placebo-controlled trial [J].
Vermeulen, EGJ ;
Stehouwer, CDA ;
Twisk, JWR ;
van den Berg, M ;
de Jong, SC ;
Mackaay, AJC ;
van Campen, CMC ;
Visser, FC ;
Jakobs, CAJM ;
Bulterijs, EJ ;
Rauwerda, JA .
LANCET, 2000, 355 (9203) :517-522
[43]  
Vollset SE, 2001, AM J CLIN NUTR, V74, P130
[44]  
Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674
[45]  
WALMA EP, 1997, HUISARTS WET, V40, P598